- Nobel Prize award: Henri B. Kagan and Kenso Soai won the Chemistry prize for solving life’s fundamental molecular asymmetry.
- Chirality breakthrough: The scientists discovered how to control chemical reactions to selectively produce single mirror-image molecules instead of standard 50/50 mixtures.
- Pharmaceutical impact: The discovery revolutionizes drug development by ensuring the creation of safe, effective molecular forms while avoiding toxic variants.
The Nobel Prize in Chemistry has been awarded to French scientist Henri B. Kagan and Japan’s Kenso Soai. They solved a fundamental chemical mystery regarding life’s asymmetry.
The researchers discovered how nature exclusively builds the correct version of a molecule instead of its mirror image.
Understanding Molecular Chirality
Amino acid molecules are the building blocks of proteins. They exist in two forms that serve as exact mirror images of each other.
Living organisms on Earth function using only one of these specific forms. The laureates answered why life favors just one of these mirror-image molecules.
In organic chemistry, this property is known as chirality. Chiral molecules possess distinct right- and left-handed forms, functioning much like human hands.
What drove the recent discovery of molecular chirality control?
Scientists were driven by the need to understand homochirality in nature. While living systems exclusively select single molecular forms, standard laboratory reactions yield a 50/50 mix. Kagan and Soai resolved this century-old puzzle by designing chemical reactions that selectively produce desired molecular versions.
Laboratory reactions usually create a balanced mix of both left- and right-handed molecules. This poses a major challenge for pharmaceutical manufacturing.
Significance for Modern Drug Development
Each mirror-image version behaves differently inside the human body. One form might fight disease effectively, while the other remains inert or toxic.
By solving this mystery, the researchers enabled better design of chemical reactions. Heiner Linke, chair of the Nobel Committee for Chemistry, announced the prize on October 7, 2026.